Cargando…

Glioblastoma: Emerging Treatments and Novel Trial Designs

SIMPLE SUMMARY: Nowadays, very few systemic agents have shown clinical activity in patients with glioblastoma, making the research of novel therapeutic approaches a critical issue. Fortunately, the availability of novel compounds is increasing thanks to better biological knowledge of the disease. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Nunno, Vincenzo, Franceschi, Enrico, Tosoni, Alicia, Gatto, Lidia, Lodi, Raffaele, Bartolini, Stefania, Brandes, Alba Ariela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345198/ https://www.ncbi.nlm.nih.gov/pubmed/34359651 http://dx.doi.org/10.3390/cancers13153750

Ejemplares similares

Glioblastoma Microenvironment: From an Inviolable Defense to a Therapeutic Chance
por: Di Nunno, Vincenzo, et al.
Publicado: (2022)

Beyond Imaging and Genetic Signature in Glioblastoma: Radiogenomic Holistic Approach in Neuro-Oncology
por: Gatto, Lidia, et al.
Publicado: (2022)

Distinct MRI pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review
por: Gatto, Lidia, et al.
Publicado: (2021)

Molecular Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma Treatment?
por: Gatto, Lidia, et al.
Publicado: (2022)

Tumor-Associated Microenvironment of Adult Gliomas: A Review
por: Di Nunno, Vincenzo, et al.
Publicado: (2022)

Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets
por: Maggio, Ilaria, et al.
Publicado: (2021)

DCVax-L Vaccination in Patients with Glioblastoma: Real Promise or Negative Trial? The Debate Is Open
por: Gatto, Lidia, et al.
Publicado: (2023)

IDH1 Non-Canonical Mutations and Survival in Patients with Glioma
por: Franceschi, Enrico, et al.
Publicado: (2021)

Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas
por: Maggio, Ilaria, et al.
Publicado: (2021)

Implications of BRAF V600E mutation in gliomas: Molecular considerations, prognostic value and treatment evolution
por: Di Nunno, Vincenzo, et al.
Publicado: (2023)

Potential protective and therapeutic role of immune checkpoint inhibitors against viral infections and COVID-19
por: Gatto, Lidia, et al.
Publicado: (2020)

Tumor Microenvironment in Gliomas: A Treatment Hurdle or an Opportunity to Grab?
por: Di Nunno, Vincenzo, et al.
Publicado: (2023)

CAR-T cells neurotoxicity from consolidated practice in hematological malignancies to fledgling experience in CNS tumors: fill the gap
por: Gatto, Lidia, et al.
Publicado: (2023)

Olfactory neuroblastoma: diagnosis, management, and current treatment options
por: Tosoni, Alicia, et al.
Publicado: (2023)

Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study
por: Brandes, Alba A., et al.
Publicado: (2017)

Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference
por: Morandi, Luca, et al.
Publicado: (2010)

Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
por: Brandes, Alba A., et al.
Publicado: (2009)

Adjuvant chemotherapy in average-risk adult medulloblastoma patients improves survival: a long term study
por: Franceschi, E., et al.
Publicado: (2020)

Diagnostic and Therapeutic Strategy in Anaplastic (Malignant) Meningioma, CNS WHO Grade 3
por: Di Nunno, Vincenzo, et al.
Publicado: (2022)

Prevalence of the single-nucleotide polymorphism rs11554137 (IDH1(105GGT)) in brain tumors of a cohort of Italian patients
por: Acquaviva, Giorgia, et al.
Publicado: (2018)

Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma
por: Schiffgens, Salveena, et al.
Publicado: (2016)

The Risk Assessment in Low-Grade Gliomas: An Analysis of the European Organization for Research and Treatment of Cancer (EORTC) and the Radiation Therapy Oncology Group (RTOG) criteria
por: Lanese, Andrea, et al.
Publicado: (2018)

Fighting cancer in coronavirus disease era: organization of work in medical oncology departments in Emilia Romagna region of Italy
por: Brandes, Alba A, et al.
Publicado: (2020)

Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO)
por: Brandes, A A, et al.
Publicado: (2006)

Rare Primary Central Nervous System Tumors in Adults: An Overview
por: Franceschi, Enrico, et al.
Publicado: (2020)

Recent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate Cancer
por: Di Nunno, Vincenzo, et al.
Publicado: (2018)

miR-196B-5P and miR-200B-3P Are Differentially Expressed in Medulloblastomas of Adults and Children
por: Visani, Michela, et al.
Publicado: (2020)

Correction: Visani et al. miR-196B-5P and miR-200B-3P Are Differentially Expressed in Medulloblastomas of Adults and Children. Diagnostics 2020, 10, 265
por: Visani, Michela, et al.
Publicado: (2021)

Resistance to Systemic Agents in Renal Cell Carcinoma Predict and Overcome Genomic Strategies Adopted by Tumor
por: Mollica, Veronica, et al.
Publicado: (2019)

The Human Microbiota and Prostate Cancer: Friend or Foe?
por: Massari, Francesco, et al.
Publicado: (2019)

Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multigene Panel
por: Malvi, Deborah, et al.
Publicado: (2022)

Key Role of Obesity in Genitourinary Tumors with Emphasis on Urothelial and Prostate Cancers
por: Santoni, Matteo, et al.
Publicado: (2019)

N-Myc a key gene promoting a worst prostate cancer progression
por: Di Nunno, Vincenzo, et al.
Publicado: (2019)

Food-induced anaphylaxis: our experience
por: Di Paolo, Camilla, et al.
Publicado: (2011)

Rational Design of Semiconductor Heterojunctions for Photocatalysis
por: Di Liberto, Giovanni, et al.
Publicado: (2021)

Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group
por: Stupp, R., et al.
Publicado: (2011)

Molecular alterations in pancreatic tumors
por: Visani, Michela, et al.
Publicado: (2021)

Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
por: Franceschi, E, et al.
Publicado: (2007)

Emerging Biomarkers in Glioblastoma
por: McNamara, Mairéad G., et al.
Publicado: (2013)

Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma
por: Singh, Kirit, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ei5p41kce6mpsoj0kqedhdtc2q